Cefozopran hydrochloride

盐酸头孢唑兰

Report date: 2026/01/13 10:03:23
NME

Base Information

Drug NameCefozopran hydrochloride
Drug Alias Name盐酸头孢唑蓝cefozopranum头孢唑兰盐酸盐头孢唑兰Firstcin +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCystitisPyelonephritisProstatitis +[27] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1995/08/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesTakeda Pharmaceutical Co LtdT's Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesT's Seiyaku Co LtdTakeda Pharmaceutical Co Ltd
Inactive CompaniesShenzhen Zhijun Pharmaceutical Co Ltd
Active IndicationsBacterial Infections
Inactive IndicationsCystitisPyelonephritisProstatitis +[26] 

Other Information

ATC CodeJ01DE03
Related LinksWikipediaKEGG